4-(Dibenzo[b,f]azocin-5(6H)-yl)-4-oxobutanoic acid

Catalog No. :
ACZXYB369
CAS No. :
1619908-20-1
Molecular Formula :
C19H17NO3
Molecular Weight :
307.35

IUPAC Name:(Z)-4-(dibenzo[b,f]azocin-5(6H)-yl)-4-oxobutanoic acid

4-(Dibenzo[b,f]azocin-5(6H)-yl)-4-oxobutanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$119.00Login to see priceIn stockInquiry
250mg95%$199.00Login to see priceIn stockInquiry
1g95%$537.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Dibenzo[b,f]azocin-5(6H)-yl)-4-oxobutanoic acid
IUPAC Name(Z)-4-(dibenzo[b,f]azocin-5(6H)-yl)-4-oxobutanoic acid
Molecular FormulaC19H17NO3
Molecular Weight307.35
SMILESO=C(O)CCC(N1C2=CC=CC=C2/C=C\C3=CC=CC=C3C1)=O
InChI KeyPMMQBJHKSUFZPX-KTKRTIGZSA-N
SynonymDibenz[b,f]azocine-5(6H)-butanoic acid, γ-oxo-;4-(Dibenzo[b,f]azocin-5(6H)-yl)-4-oxobutanoic acid;4-[2-azatricyclo[10.4.0.04,9]hexadecane-1(16),4(9),5,7,10,12,14-heptaen-2-yl]-4-oxybutanoic acid
CAS No.1619908-20-1
PubChem CID102366591

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZXYB369 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNUXT392 route compound structure diagram
    ACNUXT39223194-93-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZXYB369 route product structure diagram
    ACZXYB3691619908-20-1 In Stock
Inquiry

2. ACZXYB369 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZXYB369 route product structure diagram
    ACZXYB3691619908-20-1 In Stock
Inquiry

Comments (0)